相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo
I. V. Ulasov et al.
BRITISH JOURNAL OF CANCER (2009)
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo
M. A. Tyler et al.
GENE THERAPY (2009)
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
Matthew J. McGirt et al.
JOURNAL OF NEUROSURGERY (2009)
Designer Therapies for Glioblastoma Multiforme
Sith Sathornsumetee et al.
YEAR IN NEUROLOGY 2008 (2008)
Characterization of infectivity of knob-modified adenoviral vectors in glioma
C. P. L. Paul et al.
CANCER BIOLOGY & THERAPY (2008)
Searching for a cure - Gene therapy for glioblastoma
Paul Dent et al.
CANCER BIOLOGY & THERAPY (2008)
Low-dose radiation enhances survivin-mediated virotherapy against malignant glioma stem cells
Suvobroto Nandi et al.
CANCER RESEARCH (2008)
Targeting the Epidermal Growth Factor Receptor in High-Grade Astrocytomas
Will R. Voelzke et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2008)
Stem and progenitor cell-mediated tumor selective gene therapy
K. S. Aboody et al.
GENE THERAPY (2008)
Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis
Christine E. Eyler et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Novel cancer antiangiotherapy using the VEGF promoter-targeted artificial zinc-finger protein and oncolytic adenovirus
Yoon-A Kang et al.
MOLECULAR THERAPY (2008)
A phase I trial of Ad•hIFN-β gene therapy for glioma
E. Antonio Chiocca et al.
MOLECULAR THERAPY (2008)
Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma
Adam M. Sonabend et al.
STEM CELLS (2008)
Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus
Wison Mok et al.
CANCER RESEARCH (2007)
A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL leads to enhanced cancer cell killing in human glioblastoma models
Martin E. Wohlfahrt et al.
CANCER RESEARCH (2007)
ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo
Marta M. Alonso et al.
CANCER RESEARCH (2007)
Targeting adenovirus to CD80 and CD86 receptors increases gene transfer efficiency to malignant glioma cells
Ilya V. Ulasov et al.
JOURNAL OF NEUROSURGERY (2007)
Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma
Ilya V. Ulasov et al.
HUMAN GENE THERAPY (2007)
Comparative evaluation of survivin, midkine, and CXCR4 promoters for transcriptional targeting of glioma gene therapy
Ilya V. Ulasov et al.
CANCER BIOLOGY & THERAPY (2007)
Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: Implications for clinical efficacy
Matthieu Perreau et al.
JOURNAL OF VIROLOGY (2007)
Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma
Sophy Zheng et al.
JOURNAL OF GENE MEDICINE (2007)
Cyclophosphamide increases transgene expression mediated by an oncolytic adenovirus in glioma-bearing mice monitored by bioluminescence imaging
Martine L. M. Lamfers et al.
MOLECULAR THERAPY (2006)
Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy
Joo-Hang Kim et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma
WJ van Houdt et al.
JOURNAL OF NEUROSURGERY (2006)
Conditionally replicative adenoviral vectors for malignant glioma
AM Sonabend et al.
REVIEWS IN MEDICAL VIROLOGY (2006)
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
GM Spaggiari et al.
BLOOD (2006)
Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy
WJ Wang et al.
JOURNAL OF NEUROSURGERY (2005)
Reovirus σ1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway
Y Tsuruta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
E Zappia et al.
BLOOD (2005)
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation
M Krampera et al.
BLOOD (2005)
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms
I Rasmusson et al.
EXPERIMENTAL CELL RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: Racine and nonhuman primates
WQ Yang et al.
CLINICAL CANCER RESEARCH (2004)
Altered expression of antiviral cytokine mRNAs associated with cyclophosphamide's enhancement of viral oncolysis
H Wakimoto et al.
GENE THERAPY (2004)
AdvHSV-tk gene therapy with intravenous ganciclovir improves survival in human malignant glioma:: A randomised, controlled study
A Immonen et al.
MOLECULAR THERAPY (2004)
A phase I open-label, dose-escalation, multi-institutional trial of injection with an E1B-attenuated adenovirus, ONYX-015, into the peritumoral region of recurrent malignant gliomas, in the adjuvant setting
EA Chiocca et al.
MOLECULAR THERAPY (2004)
Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas
IM Germano et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir
PS Smitt et al.
MOLECULAR THERAPY (2003)
A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism
K Takayama et al.
VIROLOGY (2003)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
M Kim et al.
BRITISH JOURNAL OF CANCER (2003)
Regulatory approvals of pediatric oncology drugs: Previous experience and new initiatives
S Hirschfeld et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner
ZZ Su et al.
ONCOGENE (2003)
Expression of survivin in astrocytic tumors - Correlation with malignant grade and prognosis
Y Kajiwara et al.
CANCER (2003)
Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors
VW van Beusechem et al.
GENE THERAPY (2003)
Anti-erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours
G Lammering et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2003)
Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses
GG Vecil et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Clinical trials with retrovirus mediated gene therapy - what have we learned?
NG Rainov et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
RNA viruses as virotherapy agents
SJ Russell
CANCER GENE THERAPY (2002)
Caspase-8 gene therapy using the human telomerase reverse transcriptase promoter for malignant glioma cells
T Komata et al.
HUMAN GENE THERAPY (2002)
Expression of survivin in primary glioblastomas
A Das et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished
VW van Beusechem et al.
JOURNAL OF VIROLOGY (2002)
Expression in UVW glioma cells of the noradrenaline transporter gene, driven by the telomerase RNA promoter, induces active uptake of [131I]MIBG and clonogenic cell kill
M Boyd et al.
ONCOGENE (2001)
Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells
G Lammering et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Repetitive intrathecal injections of poliovirus replicons result in gene expression in neurons of the Central Nervous System without pathogenesis
CA Jackson et al.
HUMAN GENE THERAPY (2001)
Low-dose vaccinia virus-mediated cytokine gene therapy of glioma
B Chen et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015
F McCormick
SEMINARS IN CANCER BIOLOGY (2000)
Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses
AM Sandmair et al.
HUMAN GENE THERAPY (2000)
A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
NG Rainov
HUMAN GENE THERAPY (2000)
Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy
N Kuriyama et al.
HUMAN GENE THERAPY (2000)
Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter
D Vandier et al.
CANCER GENE THERAPY (2000)
Intergeneric poliovirus recombinants for the treatment of malignant glioma
M Gromeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Adenovirus-mediated transfer of Bax with caspase-8 controlled by myelin basic protein promoter exerts an enhanced cytotoxic effect in gliomas
N Shinoura et al.
CANCER GENE THERAPY (2000)
Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with recurrent malignant brain tumors
TW Trask et al.
MOLECULAR THERAPY (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models
MJ Staba et al.
CANCER GENE THERAPY (2000)
分享论文
